<DOC>
	<DOCNO>NCT01740609</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics immunogenicity single escalate dos PF-06342674 .</brief_summary>
	<brief_title>A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Male subject female nonchildbearing potential subject age 18 55 . BMI 18.5 32 kg/m2 . Total body weight ≥40 kg ≤120 kg . Previous treatment antibody within 6 month prior Day 1 . Pregnant nursing female ; female childbearing potential . History sensitivity heparin heparininduced thrombocytopenia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>RN168</keyword>
	<keyword>Healthy Volunteers</keyword>
</DOC>